Rapport Therapeutics Inc (RAPP)

Jan 9, 2025, 9:12 AM EST - 8 days ago

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

Jan 9, 2025, 7:00 AM EST - 8 days ago

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

Dec 6, 2024, 12:01 PM EST - 6 weeks ago

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

Nov 14, 2024, 7:00 AM EST - 2 months ago

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

Nov 4, 2024, 7:00 AM EST - 2 months ago

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

Oct 18, 2024, 10:51 AM EDT - 3 months ago

This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

COFS NEON PCT SELF

Sep 17, 2024, 2:35 AM EDT - 4 months ago

Rapport semestriel Pilier 3 - 30 juin 2024

Sep 5, 2024, 7:00 AM EDT - 4 months ago

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

Aug 29, 2024, 7:00 AM EDT - 5 months ago

Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen's 4th Annual Novel Mechanisms in Neuropsychiatry Summit

Jul 29, 2024, 7:00 AM EDT - 6 months ago

Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain

Jun 12, 2024, 4:01 PM EDT - 7 months ago

Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares and Concurrent Private Placement

Jun 7, 2024, 11:48 AM EDT - 8 months ago

J&J-backed Rapport Therapeutics valued at $636.8 mln after shares rise 6% in debut

JNJ

Jun 6, 2024, 7:57 PM EDT - 8 months ago

J&J-backed Rapport Therapeutics raises $136 mln in US IPO

JNJ

Jun 6, 2024, 6:54 PM EDT - 8 months ago

Rapport Therapeutics Announces Pricing of Initial Public Offering

Jun 3, 2024, 1:14 PM EDT - 8 months ago

J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO

JNJ

May 22, 2024, 4:17 PM EDT - 8 months ago

Rapport Therapeutics Seeks IPO For CNS Treatment Programs

May 17, 2024, 6:07 PM EDT - 8 months ago

J&J-backed startup Rapport files for US IPO

May 17, 2024, 4:59 PM EDT - 8 months ago

CNS disorder biotech Rapport Therapeutics files for a $100 million IPO

May 17, 2024, 4:02 PM EDT - 8 months ago

Rapport Therapeutics IPO Registration Document (S-1)